Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating 2 Dosing Regimens of TRU-015 in Rheumatoid Arthritis
This study is ongoing, but not recruiting participants.
Study NCT00634933   Information provided by Wyeth
First Received: March 5, 2008   Last Updated: October 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Active Rheumatoid Arthritis
Additional conditions recognized in this trial
Arthritis
Arthritis, Rheumatoid
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
TRU-015
Placebo
Sponsors listed in this trial
Wyeth
Trubion Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services